Abstract
Plasma fluoride concentrations and urinary fluoride excretions were measured following enflurane anesthesia (1.5%, 2 hours) in obese (8 cases) and nonobese (9 cases) patients.
At the end of anesthesia, there was no significant difference in plasma fluoride concentrations between the two groups. In the several days following anesthesia, however, plasma fluoride concentrations in obese patients were higher than those in non-obese patients.
Urinary fluoride excretions after anesthesia were greater in obese patients than those in non-obese patients, and the period of increased fluoride excretion was prolonged in obese patients.
These results suggested that obese patients metabolized more enflurane than non-obese patients during the postanesthetic period. In obese patients, their excess fatty tissue may cause a greater and more prolonged elevation of blood enflurane concentrations after anesthesia.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Taves DR, Fry BW, Freeman RB, Gilles AJ: Toxicity following methoxyflurane anesthesia II. Fluoride Concentrations in nephrotoxicity. JAMA 214:91–95, 1970
Mazze RI, Trudell JR, Cousins MJ: Methoxyflurane metabolism and renal dysfunction: Clinical correlation in man. Anesthesiology 35:274–252, 1971
Mazze RI, Cousins MJ, Kosek JC: Doserelated methoxyflurane nephrotoxicity in rats: A biochemical and pathologic correlation. Anesthesiology 36:g571–587, 1972
Young SR, Stoelting RK, Peterson C, Madura JA: Anesthetic biotransformation and renal function in obese patients during and after methoxyflurane or halothane anesthesia. Anesthesiology 42:451–457, 1975
Chase RE, Holaday DA, Eiserova-Bergerova V, Saidman LJ: The biotransformation of Ethrane in man. Anesthesiology 35:262–267, 1971
Weisberg HF: Water, electrolytes and acidbase balance. 2nd ed. Edited by Williams and Wilkins. Baltimore, 1962, pp. 43
Fry BW, Taves DR: Serum fluoride analysis with the fluoride electrode. J Lab Clin Med 75:1020–1025, 1970
Bentley JB, Vaughan RW, Gandolfi AJ, Cork RC: Halothane biotransformation in obese and non-obese patients. Anesthesiology 57:94–97, 1982
Bentley JB, Vaughan RB, Miller MS, Calkins JM, Gandolfi AJ: Serum inorganic fluoride levels in obese patients during and after enflurane anesthesia. Anesth Analg 58:409–412, 1979
Knaus RM, Dost FN, Johnson DE, Wang CH: Fluoride distribution in rats during and after continuous infusion of Na18F: Toxicol Appl Pharmacol 38:335–343, 1976
Ekstrand J, Ehrnebo M, Boréus LO: Fluoride bioavailability after intravenous and oral administration: Importance of renal clearance and urinary flow. Clin Pharmacol Ther 23:329–337, 1978
Hitt BA, Mazze RI, Beppu WL, Stevens WC, Eger II EI: Enflurane metaoblism in rats and man. J Pharmacol Exp Ther 203:193–202, 1977
White AE, Stevens WC, Eger II EI, Mazze RI, Hitt BA: Enflurane and methoxyflurane metabolism at anesthetic and at sub anesthetic concentrations. Anesth Analg 58:221–224, 1979
Torri G, Damia G, Fabiani ML, Frova G: Uptake and elimination of enflurane in man. Br J Anaesth 44:789–794, 1972
Westenskow DR, Jordan WS, Hayes JK: Uptake of enflurane: A study of the variability between patients. Br J Anaesth 55:595–601, 1983
Toyooka H, Morita S, Chinzei T, Yamada Y, Higuchi M, Akune T: Uptake rate of enflurane during closed circuit anesthesia. Jpn J Anesthesiol 33:403–408, 1984
Miller MS, Gandolfi AJ, Vaughan RW, Bentley JB: Disposition of enflurane in obese patients. J Pharmacol Exp Ther 215:292–296, 1980
Borel JB, Bentley JB, Vaughan RW, Gandolfi AJ: Enflurane blood-gas solubility: Influence of weight and hemoglobin. Anesth Analg 61:1006–1009, 1982
Vaughan RW, Miller MS, Gandolfi AJ, Bentley JB, Paplanus SH: Factors influencing enflurane disposition in the obese. Anesth Analg 59:562, 1980
Larsen OA, Lassen NA, Quaade F: Blood flow through adipose tissue determined with radioactive xenon. Acta Physiol Scand 66:337–345, 1966
Alexander JK, Dennis EW, Smith WG, Amad KH, Duncan WC, Austin RC: Blood volume, cardiac output, and distribution of systemic blood flow in extreme obesity. Cardiovasc Res Cent Bull 1:39–44, 1962–63
Lowry CJ, Sharp JH, Shumacher JE, Cousins MJ: A dose-response study in man of the metabolism of enflurane used as a supplement. Anaesth Intens Care 5:198–206, 1977
Cousins MJ, Greenstein LR, Hitt BA, Mazze RI: Metabolism and renal effects of enflurane in man. Anesthesiology 44:44–53, 1976
Aso S: Inorganic fluoride concentration and renal function after enflurane anesthesia. Jpn J Anesthsiol 32:1212–1219, 1983
Corall IM, Knights KM, Strunin L: Enflurane (Ethrane) anesthesia in manMetabolism and effects on biochemical and haematological variables. Br J Anaesth 49:881–885, 1977
Mazze RI, Calverley RK, Smith NT: Inorganic fluoride nephrotoxicity: Prolonged enflurane and halothane anesthesia in volunteers. Anesthesiology 46:265–271, 1977
Sakai T: Urinary organic and inorganic fluoride after anesthesia with fluorinated agents. Jpn J Anesthesiol 27:124–131, 1978
Jamberg PO, Ekstrand J, Irestedt L, Santesson J: Fluoride kinetics and renal function during enflurane anesthesia. Acta Anaesth Scand Suppl. 71:20–23, 1979
Dooley JR, Mazze RI, Rice SA, Borel JD: Is enflurane defluorination inducible in man? Anesthesiology 50:213–217, 1979
Maduska AL: Serum inorganic fluoride levels in patients receiving enflurane anesthesia. Anesth Analg 53:351–353, 1974
Cousins MJ, Mazze RI: Methoxyflurane nephrotoxicity-A study of dose response in man. JAMA 225:1611–1616, 1973
Author information
Authors and Affiliations
About this article
Cite this article
Tohyama, Y. Plasma fluoride concentration and urinary fluoride excretion in obese and non-obese patients following enflurane anesthesia. J Anesth 1, 148–154 (1987). https://doi.org/10.1007/s0054070010148
Received:
Issue Date:
DOI: https://doi.org/10.1007/s0054070010148